Serum calcium levels are associated with cognitive function in hypoparathyroidism: a neuropsychological and biochemical study in an Italian cohort of patients with chronic post-surgical hypoparathyroidism.

Hypoparathyroidism Neurocognitive evaluation Parathyroid hormone Post-surgical hypoparathyroidism

Journal

Journal of endocrinological investigation
ISSN: 1720-8386
Titre abrégé: J Endocrinol Invest
Pays: Italy
ID NLM: 7806594

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 09 02 2022
accepted: 06 05 2022
pubmed: 26 6 2022
medline: 14 9 2022
entrez: 25 6 2022
Statut: ppublish

Résumé

Hypoparathyroidism (HypoPT) is a rare endocrine disease and conventional therapy is based on calcium and vitamin D analogues. Conventional therapy does not restore calcium homeostasis and patients complain with neuropsychological symptoms, which have been evaluated with nonspecific self-administered questionnaires. This study aims to evaluate cognitive functions of patients with chronic post-surgical (PS)-HypoPT compared to a control population, using a standardized neuropsychological approach and evaluating the relationship with serum calcium (Alb-Ca). Observational, monocentric study on 33 patients with PS-HypoPT and 24 controls, in whom biochemical testing and a standardized neuropsychological assessment by a trained psychologist were performed. In patients with PS-HypoPT, low Alb-Ca correlated with a worse performance on semantic memory abilities and executive function, as suggested by a significant inverse correlation between Alb-Ca and Trail Making Test A (TMT-A) scores (r = - 0.423; p = 0.014) and by a positive correlation with Semantic Fluency Test scores (SF)(r = 0.510; p = 0.002). PS-HypoPT patients with Alb-Ca ≤ 8.9 mg/dl had a significantly lower test performance compared with PS-HypoPT patients with Alb-Ca > 8.9 mg/dl, both at the TMT-A test (mean score: 34.53-18.55; p < 0.0001) and at SF test (mean score: 41.94-48.68; p = 0.01) and also a significantly lower test performance compared with control patients' group at TMT-A (mean score: 34.53-25.5; p = 0.0057). Patients with chronic PS-HypoPT in conventional therapy do not show a severe cognitive impairment; however, cognitive functions namely visuo-spatial attention, executive function and semantic memory appear to be modulated by Alb-Ca and impaired by its low levels.

Identifiants

pubmed: 35751804
doi: 10.1007/s40618-022-01822-6
pii: 10.1007/s40618-022-01822-6
pmc: PMC9463210
doi:

Substances chimiques

Calcium SY7Q814VUP

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1909-1918

Informations de copyright

© 2022. The Author(s).

Références

Front Genet. 2012 Oct 02;3:200
pubmed: 23060904
BMJ. 2008 Jun 7;336(7656):1298-302
pubmed: 18535072
J Bone Miner Res. 2013 Nov;28(11):2277-85
pubmed: 23661265
Eur J Endocrinol. 2002 Feb;146(2):215-22
pubmed: 11834431
Eur J Endocrinol. 2013 May 07;168(6):895-903
pubmed: 23482593
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
J Biol Chem. 1995 Jun 30;270(26):15455-8
pubmed: 7797535
J Clin Endocrinol Metab. 2018 Feb 1;103(2):722-731
pubmed: 29099947
J Clin Endocrinol Metab. 2019 Jul 1;104(7):2748-2756
pubmed: 30776291
Front Cell Neurosci. 2018 Nov 05;12:379
pubmed: 30455631
J Clin Endocrinol Metab. 2016 Jun;101(6):2300-12
pubmed: 26943721
Endocrinol Metab Clin North Am. 2018 Dec;47(4):855-864
pubmed: 30390818
N Engl J Med. 2008 Jul 24;359(4):391-403
pubmed: 18650515
Assessment. 2017 Mar;24(2):183-196
pubmed: 26318386
J Endocrinol Invest. 2021 May;44(5):905-919
pubmed: 32926396
J Bone Miner Res. 2008 Dec;23(12):2018-24
pubmed: 18684087
Brain Res. 1986 Oct 22;385(2):227-36
pubmed: 3096491
J Biol Phys. 2009 Oct;35(4):465-80
pubmed: 19669426
Curr Opin Rheumatol. 2019 Jul;31(4):381-387
pubmed: 31107289
Front Physiol. 2017 Oct 09;8:776
pubmed: 29062283
J Clin Exp Neuropsychol. 1997 Dec;19(6):795-809
pubmed: 9524875
Int J Mol Sci. 2020 Nov 06;21(21):
pubmed: 33171939
J Bone Miner Res. 2015 Sep;30(9):1738-44
pubmed: 25753591
Nat Neurosci. 1999 Nov;2(11):941-3
pubmed: 10526330
J Intellect Disabil Res. 2005 Oct;49(Pt 10):707-17
pubmed: 16162115
JBMR Plus. 2020 Jun 05;4(7):e10368
pubmed: 32666019
Int J Mol Sci. 2021 May 06;22(9):
pubmed: 34066371
Arch Clin Neuropsychol. 2004 Apr;19(3):375-90
pubmed: 15033223
Exp Clin Endocrinol Diabetes. 1997;105(6):336-40
pubmed: 9439929
J Clin Epidemiol. 2000 Jan;53(1):1-12
pubmed: 10693897
J Endocrinol Invest. 2021 Jul;44(7):1437-1446
pubmed: 33128157
J Clin Endocrinol Metab. 2016 Jun;101(6):2284-99
pubmed: 26943720
Cortex. 2014 May;54:150-64
pubmed: 24681692
J Bone Miner Res. 2014 Nov;29(11):2504-10
pubmed: 24806578
J Clin Endocrinol Metab. 2014 Oct;99(10):3694-9
pubmed: 24978675
Neurol Sci. 2008 Sep;29(4):209-17
pubmed: 18810594
Scand J Clin Lab Invest. 1988 Oct;48(6):489-94
pubmed: 3217751
Neuroscience. 2009 Aug 4;162(1):128-47
pubmed: 19401215
J Bone Miner Res. 2011 Oct;26(10):2317-37
pubmed: 21812031
Clin Endocrinol (Oxf). 2018 Jun;88(6):838-847
pubmed: 29520810
Endocrine. 2017 Jan;55(1):256-265
pubmed: 27033542
Neurol Sci. 2013 May;34(5):749-54
pubmed: 22689311
F1000Res. 2020 Jul 23;9:
pubmed: 32765831
Pract Neurol. 2018 Jun;18(3):227-237
pubmed: 29472384
J Clin Endocrinol Metab. 2016 Jun;101(6):2273-83
pubmed: 26943719
Front Endocrinol (Lausanne). 2012 Oct 08;3:121
pubmed: 23060860
J Comp Neurol. 2007 Jun 1;502(4):563-83
pubmed: 17394159
J Bone Miner Res. 2016 Jul;31(7):1440-8
pubmed: 26865527
Clin Endocrinol (Oxf). 2003 Feb;58(2):199-206
pubmed: 12580936
Annu Rev Neurosci. 2004;27:509-47
pubmed: 15217342
Arch Osteoporos. 2020 May 19;15(1):75
pubmed: 32430780
Front Pharmacol. 2012 Apr 13;3:61
pubmed: 22518105
Eur J Neurosci. 2010 Jul;32(2):218-23
pubmed: 20646046
Neuron. 2005 May 5;46(3):401-5
pubmed: 15882639
Arch Clin Neuropsychol. 2004 Mar;19(2):203-14
pubmed: 15010086
Genes Brain Behav. 2011 Feb;10(1):90-9
pubmed: 20796031
Neurol Sci. 2014 Sep;35(9):1405-11
pubmed: 24705901
J Endocrinol Invest. 2021 Feb;44(2):245-253
pubmed: 32661948
J Clin Endocrinol Metab. 2016 Aug;101(8):3045-53
pubmed: 27186861
J Endocrinol Invest. 2022 Mar;45(3):573-582
pubmed: 34637114
Clin Neuropsychol. 2007 Mar;21(2):209-31
pubmed: 17455014

Auteurs

F Saponaro (F)

Department of Surgical, Medical, and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy. federica.saponaro@unipi.it.

G Alfi (G)

Department of Surgical, Medical, and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.

F Cetani (F)

University Hospital of Pisa, Endocrine Unit 2, Pisa, Italy.

A Matrone (A)

University Hospital of Pisa, Endocrine Unit 2, Pisa, Italy.

L Mazoni (L)

University Hospital of Pisa, Endocrine Unit 2, Pisa, Italy.

M Apicella (M)

University Hospital of Pisa, Endocrine Unit 2, Pisa, Italy.

E Pardi (E)

University Hospital of Pisa, Endocrine Unit 2, Pisa, Italy.

S Borsari (S)

University Hospital of Pisa, Endocrine Unit 2, Pisa, Italy.

M Laurino (M)

Department of Surgical, Medical, and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.

E Lai (E)

Department of Surgical, Medical, and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.

A Gemignani (A)

Department of Surgical, Medical, and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.

C Marcocci (C)

University Hospital of Pisa, Endocrine Unit 2, Pisa, Italy.
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH